Sit Investment Associates’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$660K Hold
27,428
0.01% 397
2026
Q1
$770K Hold
27,428
0.02% 382
2025
Q4
$683K Hold
27,428
0.01% 397
2025
Q3
$699K Hold
27,428
0.01% 391
2025
Q2
$665K Hold
27,428
0.01% 397
2025
Q1
$695K Hold
27,428
0.02% 393
2024
Q4
$728K Hold
27,428
0.02% 403
2024
Q3
$794K Hold
27,428
0.02% 400
2024
Q2
$767K Sell
27,428
-290
-1% -$7.98K 0.02% 378
2024
Q1
$769K Hold
27,718
0.02% 376
2023
Q4
$798K Sell
27,718
-16,090
-37% -$486K 0.02% 374
2023
Q3
$1.45M Sell
43,808
-5,450
-11% -$193K 0.04% 313
2023
Q2
$1.81M Sell
49,258
-183,575
-79% -$7.15M 0.05% 302
2023
Q1
$9.5M Buy
232,833
+19,975
+9% +$863K 0.26% 125
2022
Q4
$10.9M Buy
212,858
+165,765
+352% +$7.95M 0.31% 99
2022
Q3
$2.06M Sell
47,093
-4,139
-8% -$201K 0.06% 271
2022
Q2
$2.69M Hold
51,232
0.08% 244
2022
Q1
$2.65M Hold
51,232
0.07% 267
2021
Q4
$3.02M Hold
51,232
0.07% 270
2021
Q3
$2.2M Sell
51,232
-3,870
-7% -$171K 0.06% 285
2021
Q2
$2.16M Sell
55,102
-4,386
-7% -$171K 0.05% 288
2021
Q1
$2.15M Sell
59,488
-35,475
-37% -$1.26M 0.06% 296
2020
Q4
$3.5M Buy
94,963
+23,781
+33% +$872K 0.09% 248
2020
Q3
$2.48M Buy
71,182
+1,196
+2% +$41.9K 0.07% 258
2020
Q2
$2.17M Sell
69,986
-21,080
-23% -$716K 0.07% 268
2020
Q1
$2.82M Sell
91,066
-1,791
-2% -$61K 0.11% 222
2019
Q4
$3.45M Sell
92,857
-16,153
-15% -$575K 0.1% 227
2019
Q3
$3.72M Sell
109,010
-417,389
-79% -$15.2M 0.11% 204
2019
Q2
$21.6M Sell
526,399
-26,745
-5% -$1.06M 0.67% 34
2019
Q1
$22.3M Sell
553,144
-97,005
-15% -$3.88M 0.71% 29
2018
Q4
$26.9M Sell
650,149
-223,923
-26% -$9.3M 0.87% 22
2018
Q3
$36.5M Sell
874,072
-181,878
-17% -$7M 0.94% 21
2018
Q2
$36.3M Sell
1,055,950
-41,354
-4% -$1.41M 0.94% 21
2018
Q1
$36.9M Buy
1,097,304
+55,826
+5% +$1.92M 0.91% 23
2017
Q4
$35.8M Buy
1,041,478
+107,555
+12% +$3.67M 0.85% 28
2017
Q3
$31.6M Sell
933,923
-108,760
-10% -$3.5M 0.79% 31
2017
Q2
$33.2M Sell
1,042,683
-64,718
-6% -$2.04M 0.82% 26
2017
Q1
$35.9M Sell
1,107,401
-124,736
-10% -$3.93M 0.9% 24
2016
Q4
$38M Sell
1,232,137
-312,669
-20% -$9.55M 0.99% 18
2016
Q3
$49.6M Sell
1,544,806
-118,053
-7% -$3.95M 1.31% 8
2016
Q2
$55.5M Sell
1,662,859
-1,901,400
-53% -$60.7M 1.47% 6
2016
Q1
$100M Buy
3,564,259
+389,985
+12% +$11.1M 1.84% 4
2015
Q4
$97.2M Buy
3,174,274
+522,895
+20% +$16.4M 1.82% 4
2015
Q3
$79M Buy
2,651,379
+518,863
+24% +$16.6M 1.48% 9
2015
Q2
$67.8M Buy
2,132,516
+75,709
+4% +$2.47M 1.24% 14
2015
Q1
$67.9M Buy
2,056,807
+268,064
+15% +$8.52M 1.18% 14
2014
Q4
$52.9M Buy
1,788,743
+46,138
+3% +$1.32M 0.88% 27
2014
Q3
$48.9M Sell
1,742,605
-102,858
-6% -$2.89M 0.85% 29
2014
Q2
$52M Sell
1,845,463
-710,297
-28% -$20.2M 0.88% 26
2014
Q1
$77.9M Sell
2,555,760
-58,027
-2% -$1.73M 1.37% 9
2013
Q4
$76M Sell
2,613,787
-12,738
-0.5% -$371K 1.35% 9
2013
Q3
$71.6M Sell
2,626,525
-885
-0% -$24.1K 1.37% 9
2013
Q2
$69.8M Buy
+2,627,410
New +$72.6M 1.41% 9

Other funds holding PFE

Sit Investment Associates's PFE Position: Q2 2026 in Review

Sit Investment Associates held its Pfizer (PFE) position steady in Q2 2026 at 27,428 shares worth $660K. The position accounts for 0.01% of the portfolio, ranked #397.

Sit Investment Associates first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $100M in Q1 2016. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sit Investment Associates held 27,428 shares of Pfizer worth $660K as of Q2 2026.
  • Sit Investment Associates left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.01% of Sit Investment Associates's portfolio in Q2 2026, its #397 holding.
  • Sit Investment Associates first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Sit Investment Associates's Pfizer position peaked at $100M in Q1 2016.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sit Investment Associates's 13F filing for Q2 2026, filed 12 Aug 2026.